Search results

Records found: 2  
Your query: Author Sysno/Doc.kind = "^sav_un_auth 0239191 xcla^"

  1. 1.Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

    TitleEditorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
    Author Šíma Martin
    Co-authors Laslop Andrea
    Borg John Joseph
    Poništ Silvester 1980- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV
    Melchiorri Daniela
    Dráfi František 1984- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV
    Action VEGA č. 2/0091/23. Prínos nových nanonosičových liekových systémov k zvýšeniu protizápalového účinku D-limonénu, felandrénu, izoborneolu a chryzofanolu skúmaný in vivo. The contribution of new nano-carrier drug delivery systems to the enhancement of the anti-inflammatory effect of D-limonene, phellandrene, isoborneol and chrysophanol studied in vivo : 01.01.2023 - 31.12.2026
    COST Action CA21139. 3Rs concepts to improve the quality of biomedical science (IMPROVE). 3Rs koncepty pre zlepšenie kvality biomedicínskych vied (IMPROVE) : 21.10.2022 - 20.10.2026
    Source document Frontiers in Pharmacology. Vol. 14 , june (2023), art. no. 1228406
    CategoryBDCA - Professional papers in foreign impacted journals registered in Current Contents Connect
    Category of document (from 2022)O3 - Odborný výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2023
    DOI 10.3389/phar.2023.1228406
    article

    article

  2. 2.Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

    TitleAlzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
    Author Melchiorri Daniela
    Co-authors Merlo Sara
    Micallef Benjamin
    Borg John Joseph
    Dráfi František 1984- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV
    Action VEGA č. 2/0091/23. Prínos nových nanonosičových liekových systémov k zvýšeniu protizápalového účinku D-limonénu, felandrénu, izoborneolu a chryzofanolu skúmaný in vivo. The contribution of new nano-carrier drug delivery systems to the enhancement of the anti-inflammatory effect of D-limonene, phellandrene, isoborneol and chrysophanol studied in vivo : 01.01.2023 - 31.12.2026
    COST Action CA21139. 3Rs concepts to improve the quality of biomedical science (IMPROVE). 3Rs koncepty pre zlepšenie kvality biomedicínskych vied (IMPROVE) : 21.10.2022 - 20.10.2026
    Source document Frontiers in Pharmacology. Vol. 14 (2023), art. no. 1196413
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2023
    DOI 10.3389/fphar.2023.1196413
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all